End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.325 MYR | -4.41% | -1.52% | -1.52% |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 225.6 | 236.2 | 160.8 | 472.5 | 361.6 | 274.3 |
Enterprise Value (EV) 1 | 641.8 | 644.8 | 535.1 | 826 | 430.7 | 260.8 |
P/E ratio | 6.8 x | 2.02 x | 2.57 x | 7.31 x | 8.36 x | -3.82 x |
Yield | - | 2.38% | 6.78% | 2.44% | - | - |
Capitalization / Revenue | 1.83 x | 1.19 x | 0.73 x | 1.81 x | 1.21 x | 2.13 x |
EV / Revenue | 5.22 x | 3.24 x | 2.43 x | 3.16 x | 1.45 x | 2.02 x |
EV / EBITDA | -166 x | 82.5 x | 86.1 x | 13 x | 16.8 x | -3.95 x |
EV / FCF | -134 x | -23.7 x | 7.73 x | -6.05 x | 2.58 x | 0.87 x |
FCF Yield | -0.74% | -4.22% | 12.9% | -16.5% | 38.7% | 115% |
Price to Book | 0.36 x | 0.27 x | 0.18 x | 0.57 x | 0.3 x | 0.29 x |
Nbr of stocks (in thousands) | 281,999 | 562,281 | 545,010 | 576,241 | 716,008 | 660,883 |
Reference price 2 | 0.8000 | 0.4200 | 0.2950 | 0.8200 | 0.5050 | 0.4150 |
Announcement Date | 7/30/18 | 7/29/19 | 8/28/20 | 8/30/21 | 7/28/22 | 7/31/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 123 | 198.9 | 220 | 261.2 | 297.6 | 129 |
EBITDA 1 | -3.859 | 7.817 | 6.216 | 63.77 | 25.65 | -65.96 |
EBIT 1 | -5.814 | 5.921 | -1.113 | 56.37 | 18.64 | -72.89 |
Operating Margin | -4.73% | 2.98% | -0.51% | 21.58% | 6.26% | -56.53% |
Earnings before Tax (EBT) 1 | 37.97 | 73.84 | 54.34 | 74.66 | 42.26 | -72.07 |
Net income 1 | 33.15 | 78.2 | 62.46 | 62.8 | 37.58 | -71.17 |
Net margin | 26.96% | 39.32% | 28.39% | 24.04% | 12.63% | -55.19% |
EPS 2 | 0.1176 | 0.2075 | 0.1146 | 0.1122 | 0.0604 | -0.1086 |
Free Cash Flow 1 | -4.777 | -27.19 | 69.2 | -136.6 | 166.8 | 299 |
FCF margin | -3.89% | -13.67% | 31.45% | -52.32% | 56.04% | 231.88% |
FCF Conversion (EBITDA) | - | - | 1,113.31% | - | 650.37% | - |
FCF Conversion (Net income) | - | - | 110.8% | - | 443.79% | - |
Dividend per Share | - | 0.0100 | 0.0200 | 0.0200 | - | - |
Announcement Date | 7/30/18 | 7/29/19 | 8/28/20 | 8/30/21 | 7/28/22 | 7/31/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 416 | 409 | 374 | 353 | 69.1 | - |
Net Cash position 1 | - | - | - | - | - | 13.5 |
Leverage (Debt/EBITDA) | -107.8 x | 52.27 x | 60.22 x | 5.542 x | 2.696 x | - |
Free Cash Flow 1 | -4.78 | -27.2 | 69.2 | -137 | 167 | 299 |
ROE (net income / shareholders' equity) | 5.17% | 10.3% | 5.97% | 6.19% | 3.55% | -8.56% |
ROA (Net income/ Total Assets) | -0.29% | 0.26% | -0.05% | 2.36% | 0.82% | -3.58% |
Assets 1 | -11,440 | 29,567 | -131,495 | 2,656 | 4,602 | 1,986 |
Book Value Per Share 2 | 2.250 | 1.530 | 1.620 | 1.440 | 1.680 | 1.410 |
Cash Flow per Share 2 | 0.1300 | 0.1100 | 0.0600 | 0.1000 | 0.2800 | 0.1700 |
Capex 1 | 0.17 | 1.59 | 4.74 | 1.11 | 0.18 | 0.15 |
Capex / Sales | 0.14% | 0.8% | 2.15% | 0.43% | 0.06% | 0.12% |
Announcement Date | 7/30/18 | 7/29/19 | 8/28/20 | 8/30/21 | 7/28/22 | 7/31/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-1.52% | 45.05M | |
+40.76% | 28.24B | |
-12.43% | 26.95B | |
+21.82% | 26.45B | |
+5.54% | 25.93B | |
+50.41% | 22.95B | |
+9.30% | 20.4B | |
-2.65% | 18.55B | |
+29.64% | 16.22B | |
-13.52% | 15.1B |
- Stock Market
- Equities
- SYMLIFE Stock
- Financials Symphony Life